Objective: To identify, compare, and contrast the microbiota in patients with and without pouchitis after restorative proctocolectomy (RPC) for ulcerative colitis (UC) and familial adenomatous polyposis (FAP). Summary Background Data: Pouchitis is the most common complication following RPC. An abnormal host-microbial interaction has been implicated. We investigated the pouch microbiota in patients with and without pouchitis undergoing restorative proctocolectomy for UC and FAP. Methods: Mucosal pouch biopsies, taken from 16 UC (pouchitis 8) and 8 FAP (pouchitis 3) patients were analyzed to the species (or phylotype) level by cloning and sequencing of 3184 full-length bacterial 16S rRNA genes. Results: There was a significant increase in Proteobacteria (P ϭ 0.019) and a significant decrease in Bacteroidetes (P ϭ 0.001) and Faecalibacterium prausnitzii (P ϭ 0.029) in the total UC compared with the total FAP cohort, but only limited differences were found between the UC nonpouchitis and pouchitis groups and the FAP pouchitis and nonpouchitis groups. Bacterial diversity in the FAP nonpouchitis group was significantly greater than in UC nonpouchitis (P ϭ 0.019) and significantly greater in UC nonpouchitis compared with UC pouchitis (P ϭ 0.009). No individual species or phylotype specifically associated with either UC or FAP pouchitis was found. Conclusions: UC pouch patients have a different, less diverse, gut microbiota than FAP patients. A further reduction in bacterial diversity but no significant dysbiosis occurs in those with pouchitis. The study suggests that a dysbiosis occurs in the ileal pouch of UC RPC patients which predisposes to, but may not directly cause, pouchitis. Surg 2010;252: 90 -98) 
R
estorative proctocolectomy with ileal pouch-anal anastomosis (RPC) is the procedure of choice in patients with ulcerative colitis (UC) and selected patients with familial adenomatous polyposis (FAP). As pouchitis is a form of inflammatory bowel disease (IBD) and occurs predominantly in patients operated on for UC it may provide a model to study the underlying pathogenesis of IBD.
Whether a dysbiosis (altered gut bacterial composition) or an abnormal host immune response to normal commensal microbiota is the cause of IBD has been the subject of many studies. 1 There is evidence from clinical practice to implicate bacteria in pouchitis. Mucosal inflammation is localized to the area of gut with the highest concentration of bacteria. 2 Antibiotics have been reported to be effective treatment for both pouchitis and prepouch ileitis in up to 87.5% of patients. 3, 4 Probiotics have been shown to reduce disease relapse, 5, 6 and reduce the risk of disease onset. 7 We have previously demonstrated that the inflammatory response in pouchitis appears to be at the local mucosal level providing indirect evidence to implicate bacteria. 8 However, the microbiology of pouchitis is still poorly understood. Results from early studies of pouch microbiota using culture methods are varied and inconclusive demonstrating no strong evidence that dysbiosis is the cause of pouchitis. 9 Since the introduction of molecular techniques for the study of gut microbiology, however, it has been appreciated that culture-based studies fail to identify up to 90% of gut microbiota. 10 Studies using molecular techniques have demonstrated changes in the composition of gut microbiota in IBD patients, when compared with noninflammatory controls. Many investigators report a reduction in bacterial diversity in samples from IBD patients, often with increased Enterobacteriaceae, including Escherichia coli, and a reduction in Firmicutes including Clostridia. [11] [12] [13] [14] [15] Others have reported no differences in diversity 12, 16 or a nonsignificant increase. 17 Both increased 15,18 -20 and decreased 21, 22 levels of Bacteroidetes have been reported, likewise some studies report differences in microbiota in active and inactive disease, 19, 21, 23 whereas others do not. 18 Two studies have used a molecular technique to compare ileoanal pouch microbiota in pouchitis and nonpouchitis patients. The first bacterial DNA from mucosal biopsy samples from 11 patients was sequenced and cloned 24 with apparent significant differences between pouchitis and nonpouchitis groups. The second (from our unit) studied 32 RPC patients using terminal-restriction fragment length polymorphism. No differences between pouchitis and nonpouchitis groups were found, 17 Both of these studies, however, had limitations. First, the technique used by Johnson et al 17 was limited to only being able to identify dominant species groups and was not able to identify individual bacterial species. Second, in the study of Komanduri et al, 24 samples from groups of patients with or without pouchitis were pooled before cloning and in addition only 8 RPC samples were cloned. It is known however that there is a wide variation in gut microbiota between individuals, 25, 26 and pooling samples cannot be justified since comparisons can only be made between groups comprised of data from different individuals.
In the present study bacterial 16S rRNA gene cloning and sequencing was used and patient samples were analyzed individually to avoid the possible sources of error outlined above. Its aim was to identify, compare and contrast the microbiota in patients with and without pouchitis after RPC for UC and FAP. We also aimed to establish whether a dysbiosis occurs in pouchitis while avoiding the limitations of earlier studies. This is an expansion of the previous study 17 from our unit.
MATERIALS AND METHODS

Patients and Samples
Ethical permission for the study was granted by the local ethics committee (ethics no. 3238). RPC patients with UC and FAP attending the hospital surgical department either for routine annual review or with symptoms of pouchitis were recruited. All underwent flexible pouchoscopy with biopsy. Chronic pouchitis was defined as 3 or more episodes of pouchitis per year 27 and active pouchitis was diagnosed when the pouch disease activity index (PDAI) 28 was Ն7. Four groups of patients were studied: UC RPC nonpouchitis patients (n ϭ 8). UC RPC patients with active pouchitis (PDAI Ն7) and a history of chronic pouchitis (n ϭ 8). FAP RPC nonpouchitis patients (n ϭ 5). FAP RPC patients with active pouchitis (PDAI Ն7) (n ϭ 3).
Patients with pouchitis were treated with 4 weeks of antibiotic treatment (500 mg ciprofloxacin and metronidazole 400 mg twice daily) after which they underwent a second clinical and endoscopic assessment. Biopsies were taken before repeat pouchoscopy and discarded in those where follow-up pouchoscopy failed to demonstrate mucosal healing to exclude antibiotic-resistant pouchitis cases from this study (Fig. 1) . Inclusion criteria for UC and FAP nonpouchitis included patients with good pouch function, no previous history of pouchitis and PDAI Ͻ7. FAP pouchitis included patients with active pouchitis (PDAI Ն7). Patients with complications including retained anorectal cuff inflammation, stricture, anastomotic leakage, fistula, a history of nonsteroidal anti-inflammatory drug use, immunomodulator or other IBD therapy in the previous 2 months and those on antibiotic or probiotic therapy within the preceding 2 weeks were excluded from the study.
Mucosal Biopsy Sampling
Each patient received a phosphate enema (Forest, United Kingdom) prior to the procedure. Two mucosal biopsies (each approximately 1 ϫ 2 mm) were collected during pouchoscopy approximately 10 cm from the anal verge away from suture or staple lines. Each sample was placed in a sterile cryovial without preservative, snap frozen in liquid nitrogen and stored at Ϫ70°C until analysis. Four biopsies for routine histologic examination were taken and examined by a GI histopathologist. A medical history was taken, hospital records were reviewed and the PDAI calculated for each patient.
DNA Extraction and PCR Amplification of Bacterial 16S rRNA Genes
DNA extraction was performed on single biopsy specimens using the DNeasy blood and tissue kit (Qiagen, Crawley, United Kingdom) according to the manufacturer's instructions.
The broad-range bacterial primers Bact-7F (5Ј-AGAGTTT-GATYMTGGCTCAG-3Ј) and Bact-1510R (5Ј-ACGGYTACCTT-GTTACGACTT-3Ј) were used to amplify community 16S rRNA genes. Each 100 L PCR mixture contained 20 L of Go-Taq Buffer (Promega, United Kingdom), 3 PCR amplification was performed using a Hybaid Px2 Thermal Cycler (Thermo Scientific, Waltham, MA) with one denaturation step at 95°C for 5 minutes followed by 30 cycles of 95°C for 30 seconds, 58°C for 30 seconds, and 72°C for 2 minutes with a final elongation step at 72°C for 10 minutes.
Clone Library Construction and Sequence Analysis
Clone library construction and sequencing were performed as described previously. 29 About 192 colonies were randomly selected for sequencing from agar plates. Sequences were aligned using the NAST aligner 27 and extensive manual curation of alignments was performed using the ARB package. 30 Sequences were tested for chimeras using Mallard, 31 Bellerophon, 27 and Pintail 32 and chimeric sequences were removed. After removal of chimeras and other suspect sequences an average of 133 sequences per sample remained (3184 full-length sequences in total). These sequences (deposited in GenBank under GQ156578-GQ159761) were given a broad classification at the phylum and family levels using the Classifier tool at the RDPII website. 33 To obtain more detailed taxonomic information the sequences were divided into phylotypes. Distance matrices were generated with ARB using the Olsen correction and entered into the DOTUR program 34 set to the furthest neighbor and 99%-similarity setting. Resulting phylotypes were then assigned similarities to nearest neighbors using MegaBLAST. 35 The Shannon diversity index (SDI) for each individual sample was calculated using DOTUR. 
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Statistical Analysis
SPSS version 15 (SPSS inc. Chicago, IL) was used for all statistical analysis. For the description of data, the median and range were calculated. The Mann-Whitney U test was used to compare groups. A 2-tailed P value Ͻ0.05 was considered significant.
RESULTS
Biopsy specimens were obtained from 8 UC RPC nonpouchitis patients, 8 UC RPC patients with active chronic pouchitis who later entered clinical and endoscopic remission following antibiotic treatment, 5 FAP RPC nonpouchitis patients and 3 FAP RPC patients with active pouchitis. Clinical and demographic details are shown in Table 1 .
Sequence Analysis
In total, 3184 full-length sequences were generated from the 24 clone libraries. In common with other gut bacterial surveys, 22, 26 the majority of the sequences (99.8%) corresponded to just 4 bacterial phyla: Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. A very small number of sequences corresponded to Verrucomicrobia and Fusobacteria. As has been repeatedly shown in other studies of the gut microbiota, 22, 24 we also found a large interindividual variation.
Phylum Level Analysis Between Groups
Although the 4 phyla above were predominant in our samples it is clear that the pouch microbiota, particularly in patients with UC, is drastically different from that typically encountered in the colon. Normally the gut microbiota is dominated by Bacteroidetes and Firmicutes. In contrast, samples taken from UC RPC patients were marked by unusually high proportions of Proteobacteria (mean of around 60% of total clones) while Bacteroidetes and the major Firmicutes families Lachnospiraceae and Ruminococcaceae were, for the most part, greatly reduced. The FAP RPC samples, while still harboring relatively high Proteobacteria proportions, generally appeared to be composed of microbial communities more typical of a normal colon. When comparing the UC and FAP cohorts, there was a significant increase in the proportion of sequences in the Proteobacteria (P ϭ 0.019) and a significant decrease in the proportion of Bacteroidetes (P ϭ 0.001) phyla in the total UC compared with the total FAP patient cohort (Fig. 2 ). Similar differences were identified when the UC pouchitis group was compared with the FAP pouchitis group, with increased Proteobacteria (P ϭ 0.041) and reduced Bacteroidetes (P ϭ 0.014). When the UC nonpouchitis group was compared with the UC pouchitis group, however, there were no significant differences in the proportion of sequences from the any of the phyla (Fig. 3) .
There was also no significant difference between FAP pouchitis and FAP nonpouchitis groups (Table 2) . Therefore, at the 
Values shown are medians with range in parentheses.
FIGURE 2.
Box plot comparing the percentage of sequences identified from the 4 predominant bacterial phyla in UC patient samples compared with FAP patient samples.
phylum level, although we could demonstrate differences between the 2 different patient cohorts we were unable to demonstrate a dysbiosis within each of the 2 disease groups.
Family Level Analysis
We then attempted to pinpoint the significant differences between the samples by examining the sequence data at the family level (Fig. 4) . These results showed that the differences at the phylum level between the UC and FAP cohorts corresponded to significant increases in the levels of the proteobacterial families Comamonadaceae (P ϭ 0.007), Moraxellaceae (P ϭ 0.027), and Alcaligenaceae (P ϭ 0.03) in tandem with a significant reduction in the Bacteroidetes families Bacteroidaceae (P ϭ 0.013) and Prevotellaceae (P ϭ 0.023) and the Firmicutes family Ruminococcaceae (P ϭ 0.007) in UC. The other families identified are illustrated in Tables 1 When comparing the UC pouchitis to the UC nonpouchitis groups we found that streptococci and Alcaligenaceae were reduced in patients with pouchitis (P ϭ 0.04 and P ϭ 0.026 respectively). Enterobacteriaceae, including E. coli, accounted for the highest proportion of proteobacterial sequences and were increased in both UC pouchitis versus UC nonpouchitis and FAP pouchitis versus FAP nonpouchitis. Due to the large degree of interindividual variation between patients, however, these differences did not reach significance.
Species Level Analysis
Each patient sample was analyzed at the species level by splitting the sequences into phylotypes comprised of Ͼ99%-identical sequences using DOTUR 34 (complete details of each patient sample and the species present are provided in Tables  4 -27 When comparing the UC and FAP cohorts, Faecalibacterium prausnitzii, which has been postulated to have anti-inflammatory properties and may be reduced in IBD patients, was detected in 6 of 8 FAP patients but only 4 of 16 UC patients (P ϭ 0.029). Bacteroides vulgatus was also significantly increased in the FAP group compared with the UC group (P ϭ 0.031).
There were, however, no individual species or phylotypes that significantly differed between the UC pouchitis and UC nonpouchitis cohorts. This included both F. prausnitzii and B. vulgatus as well as other species that have previously been implicated in IBD such as Bacteroides fragilis 14 and E. coli (Table 3) . Further bacteria that have been implicated in the pathogenesis of IBD such as Mycobacterium avium subspecies paratuberculosis, sulfate-reducing bacteria, Listeria and Yersinia spp. 27 were not detected in any of the samples.
Shannon Diversity Index
Using the phylotypes generated by DOTUR we calculated the SDI, 27 which is a measure of the number of different species and their relative abundance in a given environment, for each sample and for each patient group (Figs. 4 -6 ). These are given in Table 4 (median and range shown). The median SDI for all UC RPC patients was 2.61 compared with 3.2 for all FAP RPC patients and this difference was statistically significant (P ϭ 0.004). The median SDI in the FAP nonpouchitis group was significantly higher than in the UC nonpouchitis group (P ϭ 0.019) however no difference was observed between the FAP pouchitis and UC pouchitis group (P ϭ 0.066), overall indicating that a less diverse bacterial community exists in UC RPC patients than in FAP RPC patients. Comparison within disease groups showed the median SDI in the UC nonpouchitis group was 2.70 and in the UC pouchitis group 2.32. This difference was statistically significant (P ϭ 0.009). The median SDIs in the FAP nonpouchitis and pouchitis groups were 3.19 and 3.34(P ϭ 0.18). These results demonstrate that, overall, there was a simpler, less diverse bacterial community in the UC group in comparison to the FAP group, and that a further reduction in diversity of the bacterial community occurs in patients with pouchitis. 
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DISCUSSION
It has been suggested that the term pouchitis describes a spectrum of diseases. 36 In this study, we attempted to reduce heterogeneity by studying only UC pouchitis patients with chronic pouchitis rather than all types of pouchitis. We repeated clinical and endoscopic assessment following treatment with standard combination antibiotic therapy to ensure the study group entered both clinical and endoscopic remission and to exclude patients with antibiotic resistant pouchitis. In addition, in all patients at pouchoscopy there was diffuse pouch inflammation as opposed to inflammation confined to 1 area of the pouch. No patient had risk factors for mesenteric ischemia. Therefore we believe that no patient had an ischemic component to their pouchitis. The inclusion of FAP pouchitis and FAP nonpouchitis patients is novel and allows comparison between patients with a previous history of IBD and those without. Pouchitis in FAP patients has not been well studied and its incidence is about 10 times lower than in UC patients, 37 the reasons for this are unclear. As in other studies, we analyzed the mucosal-adherent microbiota since these are likely to be more important than luminal microbiota in the pathogenesis of IBD. 15, 19, 22 This mucosal-adherent microbiota, which is in close contact with the gut mucosa, has been shown 38, 39 to be distinct from the luminal or fecal microbiota, which is comprised of free-living or particle-attached cells. The difference in community structure is likely driven by a number of factors such as differential substrate availability (eg, mucus versus undigested dietary residues), oxygen levels and host-microbe interactions. The close proximity of the mucosally-adherent microbiota to the gut epithelium means that these bacteria are presumed to be more important than luminal microbiota in the pathogenesis of IBD since they, and their excreted products, are considered more likely to have direct contact with the host. 22 The particular strengths of the present study are that we have studied pouchitis in both IBD and non-IBD RPC patients and that each sample was cloned individually and sequenced to the species/ phylotype level. To the best of our knowledge this is the first investigation in which this has been undertaken. We performed a power calculation of the study data which has shown that an estimated sample size of 8 patients per group was required to demonstrate a 5% statistical significance and 80% power in SDI between the UC pouchitis (2.35 Ϯ 0.26) versus UC nonpouchitis groups (2.75 Ϯ 0.31).
Similarly an estimated sample size of 7 patients per group was required to demonstrate a 5% statistical significance and 80% power in SDI between all UC patients (2.55 Ϯ 0.35) versus FAP patients (3.12 Ϯ 0.41).
There are, however, limitations to this present study. First, 16S rRNA gene sequencing results represent gene copy number, not true bacterial counts, and may also be biased by differential DNA extraction and PCR amplification rates. The methodology is currently, however, the best available and regarded as the "gold standard" for the analysis of gut-associated microbiota. 10 Second, the study included small numbers of patients. This is due to difficulty in accrual since patients with chronic antibiotic-dependent pouchitis are uncommon and represent about 5% of all patients. FAP RPC patients are uncommon and FAP pouchitis, particularly, is rare. 40 -44 The patient group was recruited from the largest European center and although it may have been possible to include patients from other centers this may have increased heterogeneity into the study population due to differences in the diagnostic criteria of pouchitis. Third, we included patients with chronic pouchitis who had not received antibiotic therapy for a minimum of 2 weeks. This might have influenced the gut microbiota but this cut-off was chosen for practical and ethical reasons. Others have done the same, for example in the study by Komanduri et al one patient had been treated with antibiotics 2 weeks prior to sampling. These authors reported that there was no difference in the microbiota identified in this patient when compared with those who had not received an antibiotic for 4 weeks and concluded that a 2 week wash-out period was sufficient. 25 Around 99% of gut microbiota are contained in 4 phyla; Firmicutes, Bacteroidetes, Proteobacteria, and Actinobacteria. 22, 26 At the species level however, each individual has his or her own unique gut microbiota. 24 This causes difficulty in studying gut microbiota and also demonstrates the importance of cloning and sequencing individual samples rather than analyzing pooled samples. The present study has shown that the ileal pouch microbiota is different from the normal large intestine. UC pouches in particular, with or without pouchitis, appear to harbor more unusual microbiota than FAP pouches. Proteobacteria, which normally account for only a small proportion of the microbiota in the healthy colon 39 and up to 20% of the microbiota in IBD patients 22 comprised up to 90% (median ϭ 66.6%) of the microbiota in the UC RPC patients in the study. There were also lower than normal proportions of Bacteroidetes, Lachnospiraceae and Ruminococcaceae. Comparison of the 2 study cohorts showed that UC RPC patients have increased proportions of the phylum Proteobacteria and decreased levels of Bacteroidetes compared with FAP RPC patients. A similar pattern was reported in a recent study in which surgical specimens from IBD (UC and Crohn disease) and non-IBD patient controls were compared. There was a reduction in the numbers of Bacteroidetes and Lachnospiraceae and an increase in Proteobacteria in a subset of IBD patients. 22 In other studies increases in Proteobacteria in IBD patients have also been demonstrated 12, 16 and the Enterobacteriaceae family of Proteobacteria have often been shown to be increased in IBD patients compared with controls. 14, 45 Bacterial diversity was significantly lower in UC RPC patients, with or without pouchitis, than for FAP RPC patients. Furthermore, diversity was significantly reduced in UC pouchitis patients compared with those without. It has previously been shown that VSL#3 increases bacterial diversity in pouchitis 46 and perhaps this may account for the reduced risk of relapse. A reduction in bacterial diversity has also been reported in both CD 47 and UC. 48, 49 The results of the present study therefore are further evidence of the importance of bacterial diversity in maintaining normal gut homeostasis.
Although the study aimed to establish whether a dysbiosis might be associated with pouchitis only minor differences between UC pouchitis and UC nonpouchitis were found; comparisons revealed only borderline significance between a very small number of bacterial groups. We recognize that when comparing multiple groups, significance may occur in a limited number simply by chance and have taken care not to overstate the importance of these observations. There was, however, a difference in the microbiota between the total UC RPC and FAP RPC cohorts with a reduction in F. prausnitzii and B. vulgatus in the UC RPC patient group. This is an interesting finding, given that F. prausnitzii has previously been postulated to have anti-inflammatory properties and may be reduced in IBD patients. 50, 51 In the previous study from our group using culture and T-RFLP, 17 the failure to find any differences between UC and FAP patients whether with pouchitis or not, is a reflection of the methodology which permits only cultured bacteria to be studied and is less specific and sensitive in the identification of species. The present study did find differences which not only added new information regarding the microbiota but also obtained results which are different than those of Komanduri et al. 24 These authors compared the microbiota after RPC for UC only (not FAP) in patients with and without pouchitis but there are methodological objections to the study. Length heterogeneity polymerase chain reaction was used and because this technique provides limited information about the bacterial differences at a species/phylotype level, the length heterogeneity polymerase chain reaction products from 3 non-IBD controls, 5 UC nonpouchitis, and 3 UC pouchitis patients were pooled before cloning and data were then filtered. As a result only phylotypes representing more than 5% of the total clone library were analyzed and only 73% of the microbiota were identified. The cloning and sequencing of these pooled samples identified an increase in the proportion of Enterobacteriaceae and Fusobacteria, a reduction in streptococci and a difference in the Ruminococcus species associated with pouchitis (R. obeum) and nonpouchitis (R. gnavus). In our study we studied individual patients and did not pool samples or filter our data. Using this methodology we were able to study individual species/phylotypes. The differing methodological approaches may explain the different results between the study of Komanduri et al, and ours in which Fusobacteria were not detected in the UC RPC samples and no difference was found in the proportions of Clostridium paraputrificum or Ruminococcus species in pouchitis and nonpouchitis. In our study, there was a doubling in Enterobacteriaceae in UC and FAP patients with pouchitis but this was not statistically significant owing to the high individual variation between patients, further indicating the danger of pooling samples. Indeed individual variation was so great that the numbers of patients required to detect any statistically significant difference in microbiota within UC patients would be too large to be practicable. In agreement with Komanduri et al, however, we did observe a reduction in streptococci in the UC pouchitis patients compared with nonpouchitis.
This study has demonstrated that a dysbiosis occurs in UC RPC patients when compared with a non-IBD (FAP) population. There was a reduction in diversity but only minor compositional differences between the microbiota of UC patients with active pouchitis and those with no history of pouchitis. This suggests that either this dysbiosis predisposes UC patients to pouchitis by increasing the likelihood of immune system stimulation or that the reduction in diversity is sufficient to stimulate the immune system and lead to mucosal inflammation. The failure to identify a particular bacterial species associated with pouchitis is in keeping with clinical experience where antibiotics with very different spectra of antimicrobial activity are equally effective in pouchitis. We have recently shown that many patients with pouchitis refractory to empirical antibiotic treatment have antibiotic resistant coliforms and microbiological testing is able to predict an effective antibiotic regime. 52 This, taken with the findings of the present study, suggests that antibiotic therapy is effective in pouchitis by reducing the total gut microbial load and therefore the stimulus to the immune system rather than the elimination of a specific disease-activating bacterial species.
CONCLUSIONS
This is the first study to compare the microbiota in individual patients having RPC for UC and FAP RPC using 16S rRNA gene sequencing. UC patients have a different and less diverse gut microbiota than FAP. A further reduction in bacterial diversity but only minor changes occurs in active pouchitis. The study suggests that a dysbiosis occurs in UC RPC patients which predisposes to, but does not directly cause, pouchitis.
